Patient Compliance

Shortages, confusion about access, multiple points of contact: didn't we learn anything from the pandemic about streamlining access to crucial vaccines?

SC dupilumab is used as an add-on maintenance treatment in patients with chronic obstructive pulmonary disease (COPD) with elevated blood eosinophils. 

With headlines about high flu rates in the Southern Hemisphere, unprecedented outbreaks in Japan, the UK bracing for a "cruel winter," and a new H3N2 variant that emerged after this year's vaccine was already locked in, it's not surprising that vaccine confidence may be on shaky ground. Here's how to respond to patient hesitancy.

See what your colleagues say. Take our weekly doctor poll.

Switzerland-based Novartis released results of what it called a next-generation treatment. A study of its experimental drug in 12 African countries found it works well against the mosquito-borne parasite that causes malaria and seems to block spread.

Among the issues highlighted in the report are that many patients don’t feel heard; the need to improve discharge protocols in emergency rooms; use of force for challenging behaviours; and a lack of trauma-informed obstetrical/gynecological care.

Paul Ouellet identified 13 separate instances, between May and August 2020, when he said staff were unable to serve him in French.